Neuropsychopharmacology reports
Letter to the Editor in Response to "Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta-Analysis" by Nishii et al.
Muhammad Farhan
Published: 202510.1002/npr2.70069
No abstract available for this study.